EverSource Wealth Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304 Buy
73
+15
+26% +$72 ﹤0.01% 4141
2025
Q4
$279 Hold
58
﹤0.01% 3980
2025
Q3
$293 Buy
58
+32
+123% +$141 ﹤0.01% 4052
2025
Q2
$105 Buy
+26
New +$85 ﹤0.01% 4123
2024
Q4
Sell
-12,000
Closed -$35.3K 3757
2024
Q3
$35.3K Hold
12,000
﹤0.01% 1216
2024
Q2
$39.6K Buy
+12,000
New +$40K ﹤0.01% 1194

Other funds holding SRTA

EverSource Wealth Advisors's SRTA Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Strata Critical Medical Inc (SRTA) stake by 26% in Q1 2026, buying an estimated $72 and bringing the position to 73 shares worth $304. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

EverSource Wealth Advisors first reported a position in SRTA in Q2 2024 and has held it in 6 quarters since. The position peaked at $39.6K in Q2 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • EverSource Wealth Advisors held 73 shares of Strata Critical Medical Inc worth $304 as of Q1 2026.
  • EverSource Wealth Advisors bought 15 Strata Critical Medical Inc shares in Q1 2026, an estimated $72.
  • Strata Critical Medical Inc made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #4141 holding.
  • EverSource Wealth Advisors first reported a position in Strata Critical Medical Inc in Q2 2024 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Strata Critical Medical Inc position peaked at $39.6K in Q2 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.